TARE and TACE: minimally invasive treatments for liver cancer

Interventional radiology has revolutionized the treatment of liver cancers and other vascular tumors. Two of the most commonly used minimally invasive procedures are TARE (Transarterial Radioembolization) and TACE (Transarterial Chemoembolization). Both techniques target tumors directly through the blood vessels, offering a highly effective alternative to surgery for patients who may not be surgical candidates.

In this article, we explore what TARE and TACE are, how they work, their benefits, and which patients can benefit most from these cutting-edge procedures.

What is TARE (Transarterial Radioembolization)?

TARE is a minimally invasive interventional radiology procedure used to treat liver tumors. It involves delivering tiny radioactive beads, typically yttrium-90 microspheres, directly into the arteries that supply the tumor. This allows high-dose radiation to target the tumor while sparing surrounding healthy liver tissue, making it an effective option for patients who are not candidates for surgery.

How does TARE work?

The procedure begins with careful preparation and imaging to map the liver’s blood vessels. Once ready, the interventional radiologist guides the treatment directly to the tumor through precise catheter placement.

Procedure in Steps:

Catheter Insertion: A thin catheter is inserted into the femoral or radial artery.
Guiding to the Liver: The catheter is navigated through the blood vessels to reach the hepatic artery supplying the tumor.
Radioactive Bead Injection: Microspheres containing Yttrium-90 are injected directly into the tumor’s blood supply.
Localized Radiation: The beads emit radiation over time, destroying cancer cells while sparing surrounding healthy tissue.
Permanent Placement: The microspheres remain in the tumor, providing continuous localized therapy.

Who is a candidate for TARE?

TARE is typically recommended for patients who:

Have unresectable liver tumors (cannot be removed surgically).
Are suffering from primary liver cancer (like hepatocellular carcinoma) or liver metastases from other cancers.
Have portal vein thrombosis, which makes TACE risky.
Seek localized radiation therapy as part of a minimally invasive treatment plan.
Have adequate liver function and overall health suitable for the procedure.

Benefits of TARE

Patients often experience several advantages from this procedure, making it an effective and manageable treatment option. These benefits focus on precision, safety, and convenience for liver cancer care.

Targeted Therapy: Delivers high-dose radiation directly to tumors while sparing healthy liver tissue.
Minimally Invasive: Often performed as an outpatient procedure with a shorter recovery time than surgery.
Fewer Systemic Side Effects: Compared to traditional chemotherapy, side effects are generally milder.
Safe for Portal Vein Thrombosis: Can be used in patients where TACE may be risky due to blood clot presence in liver veins.
Repeatable: Treatment can be repeated or combined with other therapies if necessary.

What is TACE (Transarterial Chemoembolization)

TACE is a minimally invasive interventional radiology procedure used to treat liver tumors. It delivers chemotherapy directly into the arteries supplying the tumor and blocks these vessels to cut off the tumor’s blood supply, maximizing treatment effectiveness while minimizing side effects.

How does TACE work?

The procedure begins with imaging to map the liver’s arteries and tumor location. The interventional radiologist then delivers chemotherapy and embolic agents directly to the tumor using a catheter.

Step-by-Step Process:

Catheter Insertion: A thin catheter is inserted into the femoral or radial artery.
Guiding to the Liver: The catheter is navigated through the arteries to reach the hepatic artery supplying the tumor.
Chemotherapy Infusion: Chemotherapy drugs are injected directly into the tumor’s blood supply.
Embolization: Tiny particles block the arteries feeding the tumor, cutting off its blood and nutrient supply.
Tumor Treatment: The tumor cells are destroyed through the combined effect of chemotherapy and lack of blood flow.

Who Can Benefit from TACE?

TACE is generally recommended for patients who:

Have liver tumors that cannot be removed surgically.
Are able to tolerate localized chemotherapy.
Require tumor control while waiting for a liver transplant.
Maintain adequate liver function and overall health to safely undergo the procedure.

Benefits of TACE

Patients undergoing TACE experience several advantages, making it an effective liver cancer treatment option:

Targeted Chemotherapy: High doses delivered directly to the tumor.
Reduced Systemic Side Effects: Minimizes impact on the rest of the body.
Tumor Shrinkage and Control: Can reduce size and slow progression.
Bridge to Transplant: Controls tumors while awaiting surgery.
Repeatable: The procedure can be performed multiple times if needed.

Key Differences Between TARE and TACE

While both TARE and TACE are minimally invasive interventional radiology procedures used to treat liver tumors, they differ in mechanism, treatment type, and patient suitability. Understanding these differences helps physicians select the most appropriate therapy for each patient.

Feature	TARE (Transarterial Radioembolization)	TACE (Transarterial Chemoembolization)
Treatment Type	Radiation-based therapy using Yttrium-90 beads	Combination of localized chemotherapy and embolization
Mechanism	Microspheres deliver radiation directly to the tumor.	Chemotherapy drugs delivered locally while arteries are blocked to starve the tumor
Primary Use	Liver tumors, including primary and metastatic	Mainly hepatocellular carcinoma (HCC)
Side Effects	Mild fatigue, temporary liver inflammation	Fever, nausea, mild liver dysfunction, post-embolization syndrome
Treatment Frequency	Usually a single session	Often requires multiple sessions depending on tumor response
Use in Portal Vein Thrombosis	Safe for patients with thrombosis	Typically avoided in thrombosis cases due to risk of liver damage

Recovery and Follow-Up

Proper recovery and follow-up care are crucial for ensuring the effectiveness of TARE and TACE treatments and for monitoring liver health.

Post-TARE Care

After a TARE procedure, most patients experience only mild side effects, and the recovery process is generally smooth:

Fatigue: Mild tiredness is common in the first few days after treatment.
Pain or Discomfort: Some patients may feel minor soreness at the catheter insertion site, which usually resolves quickly.
Liver Function Monitoring: Liver function tests are performed regularly to ensure the liver is responding well to treatment.
Imaging Follow-Up: CT or MRI scans are typically scheduled 1–3 months after the procedure to assess the tumor’s response and the placement of microspheres.
Activity and Diet: Most patients can resume normal activities within a few days but are advised to avoid heavy lifting for a short period.
Ongoing Monitoring: Regular check-ups with the interventional radiology team help track long-term outcomes and identify any potential complications early.

Post-TACE Care

Recovery after TACE may involve a few more temporary side effects due to the combination of chemotherapy and embolization:

Post-Embolization Syndrome: This can include fever, nausea, abdominal pain, and fatigue, typically lasting a few days.
Pain Management: Over-the-counter or prescribed pain medications are often used to manage abdominal discomfort.
Liver Function Monitoring: Liver enzymes and function tests are checked frequently to ensure the liver tolerates the procedure.
Imaging Follow-Up: Imaging studies are done 4–6 weeks post-procedure to evaluate tumor response and determine if additional sessions are necessary.
Repeat Treatments: Depending on tumor size, location, and response, multiple TACE sessions may be required for optimal disease control.
Activity Guidelines: Patients are usually advised to rest for a couple of days and gradually return to normal routines.

Why choose Biruni Hospital for TARE or TACE procedures?

At Biruni Hospital, patients receive world-class care for liver tumors through advanced interventional radiology techniques like TARE and TACE. Here’s why Biruni stands out:

Expert Specialists: Our team of experienced interventional radiologists specializes in minimally invasive liver cancer treatments, ensuring precise and effective care.
State-of-the-Art Technology: Biruni Hospital is equipped with the latest imaging and catheterization technology, allowing for accurate tumor targeting and optimal outcomes.
Personalized Treatment Plans: Each patient receives a customized treatment approach based on tumor type, liver function, and overall health.
Comprehensive Support: From pre-procedure preparation to post-treatment follow-up, our multidisciplinary team ensures seamless care and continuous monitoring.
Minimally Invasive Focus: Procedures at Biruni prioritize patient comfort, safety, and faster recovery, making advanced liver cancer treatment accessible without extensive hospitalization.

TARE or TACE: What to Consider

TARE and TACE are effective, minimally invasive treatments for liver tumors at Biruni Hospital, each offering targeted therapy while preserving healthy liver tissue. Choosing the right procedure depends on tumor type, liver function, and overall health. Consult an interventional radiologist at Biruni Hospital to determine the best option for your care.